LOTTE Biologics Holds Completion Ceremony for Songdo Bio Campus

Compatibilità
Salva(0)
Condividi
LOTTE Biologics Holds Completion Ceremony for Songdo Bio Campus

LOTTE Biologics Holds Completion Ceremony for Songdo Bio Campus

PR Newswire

"A New Horizon for K-Bio"

  • Completion ceremony for Plant 1 of the Songdo Bio Campus, securing a biopharmaceutical production facility with 120,000 liters of capacity
  • Leveraging large-scale production infrastructure and hands-on operating experience in the U.S., the company moves to strengthen its competitiveness in the global CDMO market

INCHEON, South Korea, Nov. 18, 2026 /PRNewswire/ -- LOTTE Biologics (CEOs James Park and Yooyeol Shin) held a completion ceremony for Plant 1 at 10:00 a.m. on the 18th at the event venue within the Songdo Bio Campus in Incheon.

Lotte Group Chairman Shin Dong-bin

Approximately 300 distinguished guests from Korea and abroad attended, including Dong-bin Shin, Chairman of LOTTE Group; James Park, CEO of LOTTE Biologics; Yooyeol Shin, CEO of LOTTE Biologics; Park Chan-dae, Mayor of Incheon; Song Young-gil, National Assembly member for Incheon Yeonsu-gu (A); Jung Il-young, National Assembly member for Incheon Yeonsu-gu (B); and Jung Kyung-sil, Director General for Health and Medical Policy at the Ministry of Health and Welfare. Prime Minister Han Seong-sook also sent her congratulations by video.

The ceremony began with a commemorative video and the pledge of allegiance, followed by opening remarks, a welcome address, and the screening of a company introduction video and congratulatory videos. Congratulatory speeches by key guests and a completion commemoration ceremony followed, after which attendees toured the main facilities of Plant 1 at the Songdo Bio Campus.

In his remarks at the event, James Park, CEO of LOTTE Biologics, said, "Plant 1 of the Songdo Bio Campus achieved GMP Ready six months ahead of the original plan. This is the result of the efforts and dedication of all our employees, and it will serve as a solid foundation for growth as we take another step forward in the global market." He added, "Based on our new mission, 'relentless pursuit of perfection and sincere dedication to life,' we will grow into a company that contributes to patients' health and a better life for humanity."

CEO Yooyeol Shin also said in his congratulatory remarks, "The completion of the Songdo Bio Campus is meaningful not only because it marks the completion of a new production facility, but because it lays the groundwork for LOTTE Biologics to contribute to strengthening the large-scale manufacturing capabilities of Korea's bio industry." He emphasized, "Under our new vision, 'The New Benchmark for Next Generation CDMOs,' we will be a CDMO partner that walks alongside our customers over the long term, built on the quality, technology, and trust they can truly feel."

Dong-bin Shin, Chairman of LOTTE Group, said in his congratulatory remarks, "The bio business is LOTTE Group's future growth engine and a next-generation industry that will lead Korea's next generation. I hope Plant 1 of the Songdo Bio Campus will become an important turning point that goes beyond LOTTE Group's growth and raises the competitiveness of Korea's bio industry to the next level." He added, "Centered on Songdo, we will create quality jobs and nurture outstanding bio talent, while working closely with the government, related agencies, customers, and partners to contribute to the development of the domestic bio industry and the strengthening of national competitiveness."

In a video message, Prime Minister Han Seong-sook said, "LOTTE Biologics' Songdo Plant 1 is the first fruit of LOTTE Group's bold, forward-looking investment in the bio industry, and it will bring new vitality to Korea's bio industry. I am confident that LOTTE Biologics will play an important role in Songdo's growth into a world-class biopharmaceutical production hub, and I hope it will lead the leap of K-Bio as a central pillar of the Songdo bio cluster."

Incheon Mayor Park Chan-dae said in his congratulatory remarks, "Last April, as a candidate for mayor of Incheon, I announced my vision for Incheon's bio industry at the LOTTE Biologics construction site, so it is all the more meaningful to see that site completed as an actual production facility. LOTTE Biologics' Songdo Plant 1 is an important asset for Incheon's leap to becoming a center of the global bio industry. I am confident that Incheon's R&D and talent development foundation, combined with LOTTE Biologics' global production capabilities, will create synergy and raise the competitiveness of the bio industry."

Plant 1 of the LOTTE Biologics Songdo Bio Campus, which broke ground in March 2024, has a total floor area of approximately 99,558 ㎡ and obtained its use approval in June 2026. It is equipped with major facilities including a production building, utility building, welfare building, and wastewater treatment plant, and has secured a total biopharmaceutical production capacity of 120,000 liters. The company explained that, following the use approval, it is carrying out preparatory procedures for commercial production, such as equipment qualification and validation, and plans to begin full-scale commercial production in 2027.

The company stated that the completion of Plant 1 at the Songdo Bio Campus gives it a large-scale production base in Korea, following Syracuse in the United States. Building on this, it plans to accelerate its business strategy linking its production hubs in Korea and the U.S. and to expand its presence in the global CDMO market. End.

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/lotte-biologics-holds-completion-ceremony-for-songdo-bio-campus-302943736.html

Immagini (1)
Recapiti
LOTTE Biologics, Sangho Lee, sangho.1ee@lotte.net, +82 10-7474-9925; LOTTE Biologics, Kihong Kim, kihongkim@lotte.net, +82 10-2489-1484